NASDAQ: SKYESkye Bioscience Inc Stock Ownership - Who owns Skye Bioscience?
Insider buying vs selling
Have Skye Bioscience Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrew J. Schwab | Director | 2025-08-22 | 6,470 | $3.42 | $22.13kSell |
| Andrew J. Schwab | Director | 2025-08-22 | 163,979 | $3.42 | $560.81kSell |
| 5am Partners VII LLC | 10% Owner | 2025-08-22 | 163,979 | $3.42 | $560.81kSell |
| 5am Partners VII LLC | 10% Owner | 2025-08-22 | 6,470 | $3.42 | $22.13kSell |
| 5am Partners VII LLC | 10% Owner | 2025-08-21 | 58,642 | $3.57 | $209.35kSell |
| 5am Partners VII LLC | 10% Owner | 2025-08-21 | 2,314 | $3.57 | $8.26kSell |
| Andrew J. Schwab | Director | 2025-08-21 | 58,642 | $3.57 | $209.35kSell |
| Andrew J. Schwab | Director | 2025-08-21 | 2,314 | $3.57 | $8.26kSell |
| Kaitlyn Arsenault | Chief Financial Officer | 2024-11-18 | 43,026 | $4.99 | $214.70kSell |
| Punit Dhillon | Chief Executive Officer | 2024-11-18 | 82,546 | $4.99 | $411.90kSell |
SKYE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SKYE insiders and whales buy or sell their stock.
SKYE Shareholders
What type of owners hold Skye Bioscience Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Versant Ventures III LLC | 1,619.72% | 501,925,802 | $2.13B | Insider |
| Emerald Health Sciences Inc | 546.68% | 169,407,901 | $719.98M | Insider |
| 5am Venture Management LLC | 31.99% | 9,913,168 | $42.13M | Institution |
| 5am Partners VII LLC | 31.24% | 9,681,763 | $41.15M | Insider |
| Andrew J. Schwab | 31.24% | 9,681,763 | $41.15M | Insider |
| Cosmas N. Lykos | 14.84% | 4,599,400 | $19.55M | Insider |
| Reg Alexander Lapham | 12.22% | 3,787,500 | $16.10M | Insider |
| Versant Venture Management LLC | 6.48% | 2,007,704 | $8.53M | Institution |
| Richard D. Squires | 4.84% | 1,500,000 | $6.38M | Insider |
| Baker Bros Advisors LP | 4.68% | 1,450,638 | $6.17M | Institution |
SKYE vs Biotech Stocks
Skye Bioscience Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.